Patents by Inventor Ludwig Miller

Ludwig Miller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pyrrolidine Main Protease Inhibitors as Antiviral Agents
    Publication number: 20240158368
    Abstract: Pyrrolidine main protease inhibitors are described that are effective as antiviral compounds.
    Type: Application
    Filed: October 12, 2023
    Publication date: May 16, 2024
    Applicant: AbbVie Inc.
    Inventors: David A. Degoey, Michael R. Schrimpf, David J. Hardee, Jacob Ludwig, Eric R. Miller, Timothy R. Hodges, Alberto Munoz, Sarah J. Perlmutter, Huan-Qiu X. Li, Alvin Jang, Elizabeth L. Noey, Gregory A. Gfesser, Edgars Jecs, Robert G. Schmidt, Justin D. Dietrich, Xenia B. Searle, Boguslaw P. Nocek, Andrew Bogdan
  • DEPLOYMENT OF A MULTI-TECHNOLOGY-STACK APPLICATION
    Publication number: 20240095003
    Abstract: Implementations(s) for deploying application(s) are described. Responsive to an indication to install a specific instance of an application registered in a registry, first and second code are retrieved from the registry to cause the installation. Responsive to the first and second code, it is detected that the first code is executable to receive information that will be generated responsive to execution of the second code; the specific instance of the second part of the application is caused to be deployed on the second TS using the fourth code identified in the second code; the information is received; and a specific instance of the first part of the application is caused to be deployed on the first TS using the third code identified in the first code and to be configured to communicate with the specific instance of the second part of the application using the information.
    Type: Application
    Filed: December 8, 2022
    Publication date: March 21, 2024
    Applicant: Salesforce, Inc.
    Inventors: Michael Dwayne Miller, Leo Duy Tran, Marshall Ludwig Hall, Natasha Sushil Gupta
  • Purification process
    Patent number: 6313289
    Abstract: Crystalline 2-(amninothiazol-4-yl)-2-(tert.butoxycarbonylmethoxyimino)acetic acid-S-mercapto-benzo-thiazolylester in form of an N,N-dimethylacetamide solvate; a crystalline salt of a 7-[2-(aminothiazol-4-yl)-2-(carboxymethoxyimino)acetamido]-3-vinyl-3-cephem-4-carboxylic acid with an amine of formula N(R1)(R2)(R3), wherein R1, R2, and R3 have various meanings, a crystalline sulphuric acid addition salt of a 7-[2-(2-aminothiazol-4-yl)-2-carboxymethoxyimino)acetamido]-3-vinyl-3-cephem-4-carboxylic acid; and the use of these salts in the production of cefixime, e.g. in form of a trihydrate.
    Type: Grant
    Filed: August 4, 1999
    Date of Patent: November 6, 2001
    Assignee: Biochemie Gesellschaft m.b.H.
    Inventors: Johannes Ludescher, Ludwig Miller, Hubert Sturm, Werner Veit, Martin Decristoforo, Siegfried Wolf